Investment Pitches

Pitch Summary:
Let's now talk about a different name: Thryv. Very basic business model, nothing too differentiated about it. I'm invested in the company, and recently increased the size of my investment, for one main reason: the leadership. It's a jockey bet. Joe Walsh successfully executed the same print to SaaS business model transition Thryv is currently undergoing at a prior company. At that company, shareholders earned a ~20x return. History doesn't repeat, but it rhymes, and great operators tend to remain great operators. Thryv participates in a massive market with countless permutations of competitors, but I think the greenfield aspect of the opportunity is often overlooked. There is ample growth to be had by simply growing into evolving demand, not necessarily stealing share from competitors. I believe that distinction is important and commonly not given enough weight. Thryv's core advantage is its ability to leverage longstanding relationships with small business owners across the country to sell locally at scale. This model allows them to more effectively capitalize on the natural evolution of SMB demand towards SaaS while maintaining a profitable business model (that is, not overspending on customer acquisition). I think it will just take solid execution for shareholders to reach a good outcome, and Joe Walsh is the guy to do it. One last note on Thryv: I highly recommend listening – not just reading the transcript – to every earnings call. The CEO and CFO have a great rapport, having worked together for something like two decades, and sometimes I think Joe Walsh doesn't prepare any notes and just talks off the top of his head; the candor is truly refreshing and appreciated.

BSD Analysis:
The manager presents Thryv as a pure management quality play, acknowledging the business model lacks differentiation but betting on CEO Joe Walsh's proven track record. The investment thesis centers on Walsh's previous success executing an identical print-to-SaaS transition that generated 20x returns for shareholders, with the manager believing great operators consistently deliver results. Thryv operates in a massive SMB market where the manager sees greenfield growth opportunities through natural demand evolution rather than competitive share gains. The company's key advantage lies in leveraging established relationships with small business owners to sell SaaS solutions at scale while maintaining profitable unit economics. The manager recently increased his position size, demonstrating conviction in Walsh's execution capabilities during the ongoing business model transition. The investment appears to rely heavily on management quality, with the manager praising the leadership team's two-decade working relationship and candid communication style. The thesis suggests patient capital can be rewarded through solid execution in a large addressable market with favorable secular trends toward SaaS adoption.

Pitch Summary:
The overarching theme of AI in consumer credit brings another portfolio name, Upstart, into the discussion. Each company approaches the problem slightly differently, but with a similarly thoughtful business model backed by focused execution. In general, I think the problem of consumer credit is a massive opportunity, AI is a perfectly matched solution, and as a result, the industry is likely to evolve significantly over time. I expect Pagaya and Upstart to be major winners from this reshuffling.

BSD Analysis:
The manager views Upstart as a complementary holding to Pagaya in the AI-driven consumer credit transformation theme. While the commentary is brief, the manager positions Upstart as having a thoughtful business model with focused execution, approaching consumer credit differently than Pagaya but with similar strategic advantages. The investment thesis centers on AI being a perfectly matched solution for the massive consumer credit opportunity, with the industry poised for significant evolution. The manager expects both Pagaya and Upstart to be major beneficiaries of this industry reshuffling, suggesting he sees substantial long-term value creation potential. The positioning indicates confidence in Upstart's ability to capitalize on AI-powered credit underwriting disruption. However, the limited detail suggests this may be a smaller position compared to Pagaya, or the manager may be grouping these AI credit plays together thematically rather than providing detailed individual analysis.

Pitch Summary:
When I started buying Pagaya in early 2024, I had no idea it would turn into my largest position today. I simply saw a disconnect between what I viewed as a founder-led company with a uniquely powerful business model and a consistent track record of growth – even through a major credit cycle – and what the market viewed as a questionable second-look loan originator. I spent a lot of effort trying to understand what I was missing or where I might be wrong but came away each time thinking if it looked and smelled like a good business, it just might be. I invested a lot of time and money into Pagaya, and it's paid off much faster than I would have guessed, though the process was accelerated by multiple expansion. In other words, more people have come around to the view it is a viable business with lots of potential, but there is still a lot of work to be done. I expect future returns to be much more closely tied to the fundamental progression of the business, but I'm in it for the long run. The overarching theme of AI in consumer credit brings another portfolio name, Upstart, into the discussion. Each company approaches the problem slightly differently, but with a similarly thoughtful business model backed by focused execution. In general, I think the problem of consumer credit is a massive opportunity, AI is a perfectly matched solution, and as a result, the industry is likely to evolve significantly over time. I expect Pagaya and Upstart to be major winners from this reshuffling.

BSD Analysis:
The manager identifies Pagaya as a misunderstood AI-powered consumer credit platform that has become his largest position. The investment thesis centers on a valuation disconnect where the market viewed Pagaya as a questionable loan originator while the manager saw a founder-led company with a differentiated business model and consistent growth through credit cycles. The manager conducted extensive due diligence to identify potential risks but concluded the fundamentals supported his bullish view. Recent outperformance has been driven by multiple expansion as market sentiment improved, though the manager expects future returns to depend more on business fundamentals. The broader thesis encompasses AI disruption in consumer credit, positioning both Pagaya and Upstart as beneficiaries of industry transformation. The manager views consumer credit as a massive addressable market where AI provides a natural solution, creating significant long-term opportunities. His conviction is demonstrated through substantial capital allocation and a long-term investment horizon despite the stock's recent appreciation.

Pitch Summary:
Planet Labs was probably the first stock I bought in significant size. I started buying in early 2023 at almost $5 per share, and for the next 18 months, the stock marched steadily lower. I bought the whole way down. Today, my average cost basis is $3.12, but the way I think about the future of the business, it shouldn't matter too much if my cost basis is $2, $5, or anything in between. If that view turns out to be reasonably accurate, I should do alright. What drew me to Planet is it being a true "one-of-one" business. Differentiation is a function of doing something differently, and Planet is very different from competitors. It designs, builds, and operates the largest fleet of earth observation satellites and has been the only company to image the entire Earth every day for eight years now. This dataset is a core, daily compounding advantage. I own the company because I believe the data it produces is immensely valuable, extremely difficult to replicate, yet still poorly monetized. Over the next decade, I expect the economic value of this data to increase non-linearly, and the gap between the value Planet creates and captures to narrow. Scaling up new constellations, increasing fusion of multiple sensors and data types, and moving further up the value chain into delivering solutions to customers, not raw data, will support this value unlock. It is much easier to sell answers than data, and AI is an accelerant to this endgame.

BSD Analysis:
The manager presents a compelling thesis on Planet Labs as a unique satellite imaging monopoly with significant untapped monetization potential. The investment centers on Planet's differentiated position as the only company providing daily global Earth imagery through the world's largest satellite constellation, creating a defensible data moat that compounds daily. The manager believes the company is undermonetizing its valuable dataset and expects non-linear value creation as Planet transitions from selling raw data to delivering actionable solutions. Key catalysts include constellation expansion, multi-sensor data fusion, and AI-powered analytics moving the company up the value chain. The manager demonstrates conviction through dollar-cost averaging during an 18-month decline, maintaining a $3.12 average cost basis. The thesis relies on the premise that Planet's unique dataset will become increasingly valuable as AI capabilities enhance data interpretation and solution delivery. The long-term value proposition appears strong given the high barriers to replicating Planet's global imaging infrastructure.

Pitch Summary:
We first detailed our thesis on AstroNova in our Q1-2023 letter and have provided numerous updates in subsequent letters. In short, our investment was predicated on the view that AstroNova was a low-risk "under-earner" with an obvious path for earnings to normalize significantly higher. So, what went wrong? To begin, the core of our original thesis proved correct: AstroNova's legacy business did experience a significant earnings inflection despite weak performance from its product identification segment. As detailed in prior letters, this recovery, while slower than we had hoped, should have been sufficient to generate attractive returns. However, despite the thesis being mostly on track, the situation would change dramatically with the acquisition of MTEX. In May of 2024, AstroNova would acquire MTEX for approximately $26 million, an amount equal to 20% of its market cap at the time, and the company was expected to contribute roughly $3 million in EBITDA that year. Instead, if we fast forward to today, MTEX is on track to lose approximately $4 million in EBITDA annually – and before you ask, no, sadly, that is not a typo. To be blunt, this acquisition was a catastrophic mistake. Making matters worse, information recently brought to light by an activist investor has deepened our skepticism of the "technology" acquired, as well as the company's decision (until recently) to continue investing in what appears to be a low-quality, cash-burning business with little high-margin recurring revenue. While one could argue that the investment would have worked out without the MTEX acquisition, that is not the correct lesson to draw from this experience. We grossly overestimated the competence and alignment of the prior management team and, crucially, we overlooked a persistent lack of transparency. Across numerous calls and three in-person meetings, we found their evasiveness strange. Their tendency to dodge questions, withhold key metrics, and always offer vague assurances like "we're working on it" were red flags that we failed to weigh appropriately. In retrospect, the persistent lack of transparency from management should have prompted a significant reduction in our position size. My rationale at the time was that our thesis did not depend on managerial excellence, only the avoidance of significant value destruction. Unfortunately, the prior CEO (Greg Woods) delivered exactly that with the MTEX deal. However, our initial analysis did include what I viewed as a safeguard against such significant value destruction: the board's experience. We placed considerable weight on the leadership of the now-former chairman, Dick Warzala. Dick has an extensive track record of successful acquisitions and strong operational skills at his own company, Allient (which we were shareholders of until recently), leading us to believe that he would provide prudent oversight at AstroNova. Further compounding our misplaced confidence in the board was another director, Alexis Michas, whose investment firm owned 7% of shares outstanding. We had viewed this combination of an experienced operator and a director with significant "skin in the game" as a strong safeguard against poor capital allocation. What we failed to appreciate, however, were the interconnected personal and professional relationships among key board members. We knew the former CEO and Dick were likely friends who had previously worked together at Danaher. We also knew that Alexis had at the very least professional ties to Dick through his involvement at Allient, where he previously served on the board and is a significant shareholder. Furthermore, we also believe a few other factors likely explain the significant governance failure surrounding the MTEX deal. The first was a lack of financial alignment; the prior chairman's stake in AstroNova was de minimis compared to his overall wealth. The second was that his own company, Allient, was facing significant destocking around the time of the MTEX deal – likely taking up the considerable majority of his time (coincidentally, this was also around when we made our first purchases in Allient). We speculate that had Mr. Warzala been more financially aligned with AstroNova or less preoccupied with Allient, the MTEX acquisition might have been prevented. As for Alexis, we believe his engagement was likely limited and his focus elsewhere since AstroNova is a small position for his fund at just low single digits. Furthermore, he is near retirement age (late 60s) and likely not as engaged in such a small position, considering that some individual investments appear to make up 20%+ of his portfolio. Publicly available text messages between him and the activist investor seem to confirm this lack of focus and concern for shareholders, in our opinion. With the above in mind, it does not seem unlikely that with both key directors distracted or disengaged, they might have put undue trust in their friend/acquaintance Greg Woods, given his track record of "acceptable" acquisitions. Thus, the board might have been too quick to approve the MTEX deal without the necessary rigor. Further supporting this idea of collegial trust is that, under normal circumstances, given Greg's repeated poor performance in recent years, a competent board would have forced him to resign shortly after the MTEX acquisition. Instead it took a 70% write-down of MTEX and a first time activist getting a full endorsement from Glass Lewis (this is practically unheard of – it genuinely might be a first) and partial endorsement from ISS before the board finally acted and subsequently forced Greg to resign – Had the annual meeting not been delayed post the forced resignation of Greg we believe the activist would have likely won multiple seats, and rightfully so in our opinion. For shareholders, the consequences of the MTEX acquisition were severe. Over the next twelve months, AstroNova's share price collapsed from $18 to a low of $7.53. The MTEX situation came to a head in late March of this year, shortly before "Liberation Day," when the company pre-released earnings and issued accompanying guidance that was highly confusing and failed to align with the known performance of the legacy business. This confusing press release made it increasingly apparent that MTEX was no longer on the path to profitability that the company had promised. Further compounding these issues was the financial strain that MTEX was now putting on the company, leading to the breach of a debt covenant. The confusing guidance issued in March was also not fully clarified for months. When it eventually was, the company revealed it was reinvesting in the acquired "technology" of MTEX for new product launches, which had the impact of negatively affecting profitability across both the legacy and MTEX segments – all while MTEX continued to seemingly burn $4M in EBITDA a year, unable to cover its own overhead. Following this press release, we decided to materially size down the position with debt now being an actual risk and Liberation Day tariffs threatening the economy (AstroNova's product identification customers are SMBs) at ~$9 a share before and after Liberation Day (roughly 30% below our cost basis). Our decision to remain shareholders, rather than liquidating the position entirely following the pre-release of earnings, was due to a single significant development: the activist campaign launched by Askeladden Capital in early April. We happen to know and are friends with the founder and portfolio manager of Askeladden Capital, Samir Patel. Coincidentally, he was the one who introduced us to the idea back in November of 2022, when we first met with Greg Woods at Southwest Ideas. Samir is an incredibly smart and talented individual who we also consider to be an honest and principled person. Furthering that last point is Samir's commitment that if elected to the board, he would NOT be taking a salary. Upon the announcement of Samir's campaign, it was immediately clear to us that he had a formidable case for change and a high probability of winning the ensuing proxy contest. From our perspective, AstroNova was a textbook case for shareholder activism. This initial assessment would subsequently be validated when Samir would later garner the previously mentioned full endorsement from Glass Lewis and a partial endorsement from ISS. Since the Glass Lewis endorsement, the changes at the company have been swift and not immaterial. The former CEO, Greg Woods, was forced to resign; the board has reversed its stance on Samir, shifting from criticism to public support for several of his statements; and the recently elected independent director, Dairus Nevin, has been appointed Chairman. Furthermore, the new CEO's compensation package includes a significant "change in control" provision, strongly suggesting a new strategic direction for the company: improving operations over the next 12-24 months in preparation for a potential sale of the entire business or one of its divisions. It should be noted that AstroNova has yet to announce a settlement with Askeladden Capital, and while we aren't sure what the outcome will be, we believe that the recent cessation of public communication between the two potentially signals ongoing negotiations that are hopefully headed towards a mutually agreeable outcome. While I don't like giving any weight to share price reactions, the market seems to agree that the recent developments are a step in the right direction as well. The day of Greg's forced resignation, AstroNova's shares rallied ~25% and now stand at ~$12, up from lows in the $7's. AstroNova serves as an important reminder that a competent and aligned management team is an essential part of any thesis, a rule of mine that I broke given AstroNova's clear visibility to an earnings inflection, and what we perceived to be a competent board. While I was correct on our original thesis, none of that matters when the company does an acquisition that's 20% of their market cap, finances that acquisition with debt, but turns out to be losing $4M a year compared to the original estimates of a $3M profit. The ultimate error, however, was not our initial investment in AstroNova, but my failure to significantly reduce our position shortly after the MTEX acquisition when cracks began to show. Doing so would have resulted in a slight gain on our initial investment and the opportunity to allocate the proceeds elsewhere to better ideas.

BSD Analysis:
The manager's AstroNova investment illustrates how poor capital allocation can destroy an otherwise sound turnaround thesis. The original "under-earner" thesis proved correct as the legacy business experienced the expected earnings inflection, but management's catastrophic MTEX acquisition for $26 million (20% of market cap) completely derailed shareholder value. MTEX was projected to generate $3 million in EBITDA but instead loses $4 million annually, representing a $7 million annual swing that breached debt covenants. The manager correctly identifies governance failures stemming from board members' personal relationships and misaligned incentives, with the chairman having minimal financial stake and being distracted by his own company's issues. The activist campaign by Askeladden Capital has catalyzed meaningful change including CEO resignation and new leadership focused on potential asset sales. The position has recovered from $7.53 lows to $12 following management changes, suggesting the turnaround thesis may still be viable under competent leadership.

Pitch Summary:
I first wrote about Cable One in our Q1 2023 letter, nearly three years ago. I won't rehash the full thesis here and would point you to that letter for more detail, but at a high level, we invested in Cable One under the belief that its rural Hybrid Fiber-Coaxial (HFC) network would remain defensible against both fiber overbuilders, such as AT&T, and fixed wireless access (FWA) providers like T-Mobile, enabling Cable One to continue subscriber, revenue, and EBITDA growth (even if at a slower pace). However, over the following two and a half years, that thesis unraveled. Cable One's HFC network went from roughly 30% overbuilt (which mainly was the large population centers of their footprint) to more than 60%, so in short, we were wrong. It turned out that Cable One had pushed ARPUs high enough that it became economically viable for AT&T, Lumen, and others to overbuild their more rural markets. The footprint that we initially viewed as a strength turned out to be a double-edged sword for the company: while it had enabled ARPUs well above industry peers for many years due to limited competition it is now significantly overbuilt and Cable One is being forced to compete against non-powered fiber lines (which are cheaper to maintain and a superior product), and whose providers can and have been undercutting them on price. This is a challenging setup for Cable One. Not only do they risk ongoing subscriber losses, but maintaining competitiveness might ultimately require price cuts, which carry high decremental margins. So far, they have managed to hold pricing reasonably well, but the trade-off has been accelerating data subscriber losses. Eventually, they will likely have to cut pricing or risk losing even more customers. Thus far, Cable One has seen a decline in both its top and bottom lines, despite passing 6.5% more homes than when we first invested. Adding fuel to the fire is Cable One's balance sheet, which is now levered at greater than four times, which under a par-for-the-course operating environment would not be a problem for this business, but with EBITDA declining, data subscriber losses accelerating, and the MBI put-option coming up in 2026 has made the company's equity effectively behave more like a "stub," now trading at $150 per share - 5x EBITDA. However, to say I was ignorant of any of these risks would not be accurate, and thus the position was sized conservatively from the get-go. Even at its peak, Cable One never exceeded a mid-single-digit position in the portfolio, and we made just one minimal addition over our two years of ownership before exiting entirely around $250 per share when it became clear that our thesis was wrong and that subscriber losses were likely to be accelerating.

BSD Analysis:
The manager's Cable One investment represents a classic value trap scenario where a seemingly defensible rural cable franchise deteriorated rapidly due to competitive pressures. The original thesis centered on Cable One's rural HFC network providing protection against fiber overbuilders and fixed wireless competitors, but this proved fundamentally flawed. The company's high ARPU strategy backfired as it made rural overbuild economics attractive for AT&T and Lumen, increasing competition from 30% to 60% of their footprint. Cable One now faces the difficult choice between maintaining pricing and losing subscribers or cutting prices with high decremental margins. The balance sheet leverage of 4x+ EBITDA compounds the problem as earnings decline, creating a "stub equity" situation trading at just 5x EBITDA. The manager appropriately sized the position conservatively and exited around $250 when the thesis broke down, demonstrating disciplined risk management despite the fundamental misjudgment of competitive dynamics.

Pitch Summary:
@ToffCap presents 2CRSi as a small-cap turnaround evolving into a potential AI infrastructure beneficiary. The pitch centers on a dramatic acceleration in order intake for AI-optimized servers, which the author believes is not yet fully reflected in valuation despite a sharp share-price rerating. 2CRSi is framed as moving from a marginal, forgotten server vendor into a credible supplier of high-density, energy-efficient hardware aligned with AI data center demand. The investment appeal lies in a combination of hypergrowth, operational turnaround, and a valuation that appears low relative to forward EBITDA and growth rates. However, the author explicitly flags discomfort with position sizing due to limited industry familiarity and rapid structural change in AI infrastructure. The request for community input underscores uncertainty around durability and competitive positioning. The stance is Bull, driven by momentum, transformation, and valuation asymmetry, but tempered by acknowledged execution and industry risks.

BSD Analysis:
2CRSi sits in a highly competitive but capacity-constrained segment of the AI supply chain, where demand for GPU-dense, power-efficient servers has surged faster than incumbent vendors can respond. The company’s recent contract wins suggest it has crossed an important credibility threshold, moving from niche supplier to production-scale partner for AI workloads. Margin expansion potential hinges on mix shift toward AI servers and the successful layering of services, which could structurally re-rate the business away from pure hardware cyclicality. Key risks include dependence on NVIDIA GPUs, exposure to export controls, and execution strain as a relatively small organization scales globally. The valuation argument is compelling if backlog converts cleanly and services margins materialize, but downside scenarios involve order lumpiness and competitive responses from larger OEMs. This is best underwritten as a high-beta AI infrastructure optionality play rather than a steady compounder.

Actual Post Content:
Just published on a new company, and this is one I’m going to need your help with. No paywall on this one. Despite having done little work on the industry, I took as small position in 2CRSi a few months back with the intention to scale it up as we did the works. I figured that the current order momentum was still not nearly being reflected in the price, and we could at least play this one for a short rerating. Well, the market clearly woke up on this one. Our smallish position is up plus 160 percent and we’re hitting ourselves for having postponed the hard work to today. Despite the recent move, the valuation does not seem right given the ongoing transformation, growth and hype potential. We’re doing work on it but we are still uncomfortable sizing this one up properly; it’s an industry that is changing rapidly, with a lot of moving pieces. With our still sub-par understanding of the industry and the story moving fast, I felt it would be good to put this one out there, asking knowledgeable people for their input. So, in short: Is 2CRSi a hidden gem or not. Any help is appreciated. In short, 2CRSi seems to be successfully transforming itself from a forgotten player in the server world into a pretty interesting player in the global AI infrastructure race. Today, 2CRSi is notable for three things. The company has an ugly name and an annoying ticker. Its order book is on fire. A nice string of massive order wins is transforming the company’s outlook over the next years. Not expensive at all given what’s already in the pipeline, less than seven times EV EBITDA looking out a few years, for more than 100 percent growth per annum.

URL: https://x.com/ToffCap/status/1955984045340242310

Pitch Summary:
IHS Holding (IHS) is undertaking a strategic review focused on unlocking shareholder value through portfolio optimization and balance-sheet repair. Since announcing the review in March 2024, the company has executed asset disposals at attractive valuations, most notably selling its Kuwait operations at ~14× adjusted EBITDA while the stock trades near ~6×. Additional exits from Rwanda, Egypt, and Peru reinforce management’s intent to streamline the footprint and recycle capital. IHS is targeting $500m–$1bn of proceeds, primarily earmarked for debt reduction, with optionality for buybacks or dividends if excess cash emerges. The market reaction has improved, with renewed price momentum suggesting growing confidence in execution.

BSD Analysis:
The telecom tower industry is structurally defensive, underpinned by long-duration contracts, inflation-linked escalators, and rising data consumption, but leverage and geographic complexity can obscure value. IHS’s competitive position has been diluted by exposure to higher-risk markets, making portfolio rationalization a sensible path to surface underlying asset quality. Selling non-core assets at private-market multiples well above public valuation highlights a material disconnect between intrinsic and traded value. Deleveraging is the key catalyst, as reduced financial risk would materially lower the equity risk premium and improve capital allocation flexibility. The main risk is execution fatigue—continued disposals must not erode scale advantages or tenant diversification. Secular demand remains supportive, but multiple expansion hinges on balance-sheet credibility rather than growth. At current levels, the stock appears priced for stagnation despite clear evidence of value realization. If management sustains disciplined asset sales and redeploys capital efficiently, equity re-rating potential is meaningful.

Actual Post Content:
Starting to do some work on $IHS. I like the renewed price momentum on the back of good asset disposal strategy (so far), selling assets for 14x ev/ebitda while trading at 6x. In short: In March 2024 $IHS announced a strategic review aimed at creating greater value for shareholders. A key focus of this review has been optimizing its portfolio and improving financial performance. $IHS targets $500m to $1bn through asset and market disposals, with the proceeds primarily directed toward reducing debt. The results so far have been interesting. In December 2024 $IHS completed the sale of its Kuwait operations for 14.2x adj ebitda. By mid-2025, the company had exited three additional markets—Rwanda, Egypt, and Peru. Debt reduction remains a top priority, but $IHS is keeping its options open. Management signaled that excess cash flow could also support share buybacks or even the introduction of a dividend policy. At the same time, they continue to explore additional strategic actions, believing that the company’s share price does not fully reflect its underlying value. Happy to hear more from people involved.

URL: https://x.com/ToffCap/status/1955602233959039472

Pitch Summary:
Adyen reported mixed results—strong profitability but revenue slightly below expectations, leading the market to sell aggressively. Revenue grew 20% YoY, but processed volume growth was affected by a large customer headwind. The company cut its second-half revenue growth outlook due to tariffs and FX, dampening acceleration expectations. Segment growth was still solid across digital, unified commerce, and platforms. Margins remain strong and are expected to expand. The pitch argues that long-term fundamentals remain sound though near-term sentiment is weak.

BSD Analysis:
Adyen remains an advantaged global payment processor with high switching costs and scalable infrastructure. Growth normalization and large-merchant concentration create volume volatility, but long-term secular tailwinds in e-commerce and omnichannel should support revenue expansion. Tariffs and FX are temporary headwinds highlighting geographic exposure. Margin strength reinforces durable economics despite near-term growth resets. Competitive pressures from Stripe and others persist but Adyen’s integrated platform remains differentiated. The selloff likely embeds pessimism, creating optionality if execution stabilizes.

Actual Post Content:
$ADYEN out with results, and the market is at it again, pushing the shares down ~20%. 📊 Net revenue: €1.09B (+20% YoY, +21% cc), missing estimates of €1.11B. 💰 ebitda: €543.7M (+28% YoY), with a margin of 50%, slightly above expectations (49.6%). 💳 Processed Volume: €649B (+5% YoY), but excluding a large-volume customer, growth was robust +23%, though it fell short of the €662.19B css estimate. Business Segments: 🌐 Digital Revenue: €638.9M (+10% YoY). 🛍️ Unified Commerce Revenue: €334.1M (+31% YoY). 🔗 Platforms Revenue: €120.5M (+55% YoY). Adyen revised its H2 2025 revenue growth outlook to +20-21% (cc), down from +24%, citing U.S. tariffs and currency fluctuations. The company now sees full-year revenue acceleration as unlikely but expects ebitda margin expansion in 2025; ccs ebitda margin of 52% is probably too high. "Following lower-than-expected market volume growth in the first half, we now consider the previously anticipated acceleration unlikely. We expect this trend to persist through the remainder of the year..." Overall mixed results show strong profitability but slower than expected growth, with external headwinds such as U.S. tariffs impacting performance. Long-term potential remains intact, but short-term challenges are weighing on sentiment... and we know how fickle investors can be with this company... $ADYEY

URL: https://x.com/ToffCap/status/1955895089475014920

Pitch Summary:
The author argues that PPIH is a mispriced industrial company with strong multiyear growth drivers centered on Middle Eastern infrastructure expansion. Saudi Vision 2030 and related energy, cooling, and pipeline projects are expected to sustain high demand for Perma-Pipe’s pre-insulated systems. A growing presence in Qatar adds a new high-growth market with early commercial traction. The company’s backlog has surged to record levels, providing visibility into future revenue. Meanwhile, the PermAlert leak-detection division is being scaled with newly hired enterprise sales staff and could meaningfully expand PPIH’s addressable market, particularly in data centers. The author believes PPIH can earn $2.50–$3.00 EPS within a year, implying a single-digit P/E. The stock is viewed as undervalued with both operational momentum and optionality from PermAlert.

BSD Analysis:
PPIH sits in a niche but structurally attractive corner of industrial infrastructure tied to district cooling, oil & gas transport, and corrosion-resistant piping—areas with long-cycle demand and project visibility. The MENA region is undergoing a generational capex cycle that could support earnings durability unusual for a company of this size. The combination of a strong balance sheet, high-margin specialized products, and exposure to mission-critical applications gives PPIH a defensible position. PermAlert adds a higher-margin, tech-like layer that could rerate the company if adoption in data centers accelerates. The main risks include customer concentration, project timing, and geopolitical exposure. However, the asymmetric nature of the backlog and margin expansion opportunities suggests an embedded earnings-power step-up not fully captured by standard industrial comps. Execution on both core piping projects and PermAlert commercialization is key to unlocking the valuation gap.

Actual Post Content:
LONG POST $PPIH. I’m bullish about $PPIH, which I view as an undervalued small cap with substantial growth potential. My investment thesis centers on the strength of its legacy Perma-Pipe business, which is poised for a robust performance in 2025 driven by major infrastructure projects in the Middle East. These initiatives are largely fueled by Saudi Arabia’s Vision 2030, a comprehensive plan to diversify the economy and invest heavily in energy, industrial, and urban development sectors. This long-term vision ensures sustained demand for Perma-Pipe’s pre-insulated piping systems for years, which are essential for district heating, cooling, and oil and gas transport in harsh environments. A key highlight is the company’s expanding presence in Qatar, where it recently secured its first project a $2.4 million contract for anti-corrosion coating services in the oil and gas market. This marks a strategic entry into a high growth region, and I anticipate further wins as Qatar ramps up its infrastructure investments, including natural gas expansion and urban projects. Overall, these Middle Eastern opportunities have contributed to a record-high backlog, which has surged to over $131 million in April, which is major increase year-over-year versus the same time in 2024, and is ultimately bolstered by key contracts across Saudi Arabia, the UAE, and now Qatar. This backlog provides strong visibility into future revenue and underscores the durability of $PPIH core operations. Shifting focus to the PermAlert division, which specializes in advanced leak detection systems, the company has recently onboarded experienced enterprise sales professionals to accelerate market penetration. These hires bring deep expertise in data center solutions, and I expect them to drive meaningful top line growth through the promotion of PermAlert’s cutting edge leak detection technology. This system offers precise, real-time monitoring for liquids in critical applications, reducing risks in industries like energy and data centers, and positions PermAlert for expanded adoption in new sectors. In conclusion, even excluding the emerging data center segment where the $PPIH leak detection solution could drive signifiant upside the business is on track to potentially deliver $2.50-3 in earnings per share over the next 12 months. This projection is supported by the company’s strong backlog, revenue momentum, and operational efficiencies. PermAlert is entirely just upside on top of my estimate. If they deliver $2.50 EPS, then the company is trading at a 13 P/E today. If they can get close to $3 EPS, then the company is a 9 P/E. This should also be accompanied by double digit top line growth. PermAlert contribution is an unknown, but could bring upside to my numbers above.

URL: https://x.com/KyleAdamsStocks/status/1955841007091679596

Pitch Summary:
The pitch argues the market is underappreciating the potential upside for Vivid Seats from renewed touring activity by Taylor Swift. Swift’s Eras Tour was the highest-grossing tour of all time and a material demand tailwind for ticket resellers, with management previously guiding that results were unusually first-half weighted due to Swift-related activity. Vivid Seats has explicitly cited Swift-driven surges in traffic, pricing, and even sports ticket demand following her public appearances. While 2024 saw a concert revenue decline as Swift did not tour, the pitch frames this as evidence of her outsized impact rather than structural weakness. With a relatively small market cap, the author views the stock as offering attractive risk/reward ahead of any confirmation of a new tour, arguing that once announced, upside would already be priced in.

BSD Analysis:
Secondary ticketing is structurally volatile, but blockbuster global tours function as demand shocks that disproportionately benefit scaled marketplaces with strong liquidity and discovery. Vivid Seats’ competitive position improves materially during such periods due to operating leverage, cross-category spillover into sports, and pricing power on scarce inventory. Swift represents an unusually concentrated demand driver, creating episodic earnings power that the market tends to discount due to timing uncertainty. The key risk is over-reliance on singular artists, as seen by the post-Eras normalization in 2024, which compresses multiples absent visible catalysts. However, optionality around future tours is asymmetric, as incremental volume flows largely to the bottom line. Valuation at a subscale market cap implies limited credit for another mega-tour cycle. If Swift resumes touring, or announces high-profile residencies, earnings expectations would likely reset quickly. The setup favors investors willing to underwrite catalyst uncertainty in exchange for convex upside.

Actual Post Content:
I think the market is completely asleep at the wheel here. On the TS album announcement. Her Eras tour was the biggest $ of all time. Was a MAJOR tailwind for ticket resellers like $SEAT with their mcap at 177mil, think good r/r once mkt catches up. Q2 2023 earnings call (management commentary): Vivid Seats explicitly said results would be “more first half weighted than normal due to significant contribution in the first half from Taylor Swift At William Blair’s conference, management described “a record setting concert environment” in 2023 with “Taylor Swift and Beyoncé and people paying $10,000 to see the Eras Tour,” Swift “effect” on Vivid Seats demand (sports cross-over): After Swift appeared at a Chiefs game in 2023, Vivid Seats reported traffic to the Chiefs-Jets game page up 173%, Chiefs team page up 126%, and average prices up 14%—a clear, Swift-driven boost on the platform Sports Business Journal noted concert revenues fell 8% for Vivid Seats in 2024 and pointed out that Swift “won’t be touring in 2025 for the first time in two years”—context that highlights how outsized tours like Eras had been a tailwind and their absence is a headwind. Once they confirm a tour / it will be too late imo as the street will be alive to the situation. Die will be cast so to speak. Also, rumours of her playing the $sphr I can’t see Swifty leaving billions on the table and not touring. She’s an astute 👩‍💼

URL: https://x.com/richtrades100/status/1955992819799109980

Pitch Summary:
2CRSi is undergoing a significant transformation from a struggling server manufacturer to a key player in the AI infrastructure market. The company has successfully restructured by divesting non-core assets and focusing on its core competency of building powerful, energy-efficient computing infrastructure. This strategic pivot aligns with the global surge in demand for AI-capable hardware, positioning 2CRSi to capitalize on the AI infrastructure buildout. Recent financial performance has been strong, with revenues and profitability rebounding sharply, driven by substantial new orders and a growing presence in key markets like the US and UK. Despite a recent stock price increase, the valuation remains attractive given the company's growth trajectory and the secular tailwinds in the AI sector.

BSD Analysis:
2CRSi's resurgence is supported by its strategic entry into the North American market and significant contract wins, including a $100 million deal in the US and a €47 million contract in Malaysia. These deals highlight the company's ability to compete with larger players and validate its product offerings. The company's shift towards a services-oriented model, exemplified by the '610 contract', is expected to enhance margins and provide recurring revenue streams. However, reliance on NVIDIA chips poses a geopolitical risk, and the company's ability to execute large-scale projects remains a challenge. Nonetheless, the combination of operational momentum, sector tailwinds, and valuation disconnect presents a compelling investment opportunity.

Pitch Summary:
Ohio-based Tier-1 supplier of seating, mirrors, harnesses, and cab components for medium/heavy-duty trucks, ag, and construction equipment. Operates through Seating (~45% sales), Electrical (~30%), and Trim (~25%). Shares collapsed ~40% in past year due to cyclical Class 8 truck downturn, higher-than-normal SG&A (10%+ vs. 7–9% history), and exclusion from Russell 2000. Current TEV of ~$145M implies <3× mid-cycle EBITDA and ~0.5× tangible book. Management guided to $22–25M EBITDA near-term, but mid-cycle history supports ~$50M. New Chairman Bill Johnson is pushing for sharper SG&A discipline, while cost-out initiatives could deliver $15–20M in savings as volumes recover. With $90M undrawn ABL (exceeding market cap), liquidity is not a risk. PE interest and activist shareholder 13D suggest optionality for takeout. Rumored buyers could unlock value via synergies, SG&A cuts, and elimination of public costs. Historically produced 12% ROIC and $82M FCF (2018–23), exceeding current market cap.

BSD Analysis:
CVGI trades at distressed multiples due to a mix of cyclical softness and operational missteps, but asset coverage, liquidity, and mid-cycle earnings power are underappreciated. At ~$50M normalized EBITDA, applying even 4.5× yields >2× upside. Tangible book provides downside support, and historic FCF generation confirms the model works through cycles. Activism and potential PE involvement add a catalyst path, especially given clear SG&A fat (20–30% cut potential) and ~$5M annual public company costs to eliminate. Chair Johnson’s turnaround background raises odds of internal improvement or sale. Near-term risks: continued Class 8 softness, Trump admin delay of emissions-driven pre-buy hurting order timing, and unproven execution by current CEO. Still, the asymmetry is notable: distressed multiples, credible cost-out levers, asset-backed liquidity, and external interest. This is a cyclical recovery + special situation setup where PE optionality provides a free call option.

Pitch Summary:
The pitch centers on owning the REE bottleneck—separation/refining—rather than mining, given China’s ~90% processing dominance. Ucore’s RapidSX aims to modernize solvent extraction via modular, column-based, sensor-rich (600+ sensors) trains that claim 3–10× throughput in ~⅓ the footprint, lowering capex/opex vs mixer-settlers. A Louisiana Strategic Metals Complex (in an FTZ at England Airpark) underpins the U.S. footprint; Kingston (Ontario) demo runs are cited to validate flowsheets for LREE/HREE. DoD has awarded ~$22.4m (non-repayable OTA) toward the first commercial RapidSX machine focused on heavy REEs (Dy/Tb et al.). Author posits Stage-1 capacity of ~2,500 tpa TREO (~$150m rev; low-teens EBITDA), scaling to 5,000–10,000 tpa with rising margins; additional upside from offtakes, licensing and JVs. Policy tailwinds (U.S. critical-materials funding) and FTZ logistics potentially de-risk feedstock imports/exports. Capital need to complete phases is ~$100m (blend of equity/strategic/DoD). Comparisons to MP’s valuation frame large upside if Ucore proves commercial purity/yields at scale. Catalysts: uplist, more DoD support, strategic investor, research coverage.

BSD Analysis:
Processing leverage is the right place to fish: separation is the scarce, policy-supported node with potential for durable economics. RapidSX’s claims (throughput, footprint, automation) are appealing, but the thesis lives or dies on commercial proofs—magnet-grade purity, stable yields, uptime—and binding offtakes with bankable counter-parties. Funding is the second gate; $100m+ across phases likely means dilution unless offset by grants/pre-pays; structure and cost of capital will drive per-share outcomes. Feedstock security (non-Chinese, HREE-rich concentrates) must be contracted on consistent specs; variability can erode margins and ramp timelines. IP risk looks mitigated post-IMC acquisition, but any challenge or process drift would impair licensing optionality. Using MP as a comp is aspirational near term; a more sober base case values Stage-1 EBITDA at a mid-teens multiple, then layers probability-weighted options for Stage-2/3 and licenses. Key signposts: EPC/commissioning milestones, third-party assays (99.9x% specs), unconditional offtakes, and incremental U.S. funding. If Ucore executes, upside can be material; absent that, this remains a high-beta, milestone-driven story with policy support but non-trivial scale-up risk.

Pitch Summary:
Manitoba-based junior evolving from nickel explorer into a diversified critical-metals developer. Flagship Donner Lake lithium-cesium project already secured an offtake with Tanco (North America’s only cesium producer) and mill lease at True North, enabling monetization without major capex. Falcon West shows some of the highest cesium grades outside Tanco, plus REE upside. Makwa-Mayville Ni-Cu-PGM project de-risked via JV with Teck Resources (up to 70% earn-in). Cesium is the strategic angle: ultrarare, dominated by China (Sinomine controls Tanco & Bikita), no substitutes in defense/telecom/AI hardware. Backed by Waratah (19%), AMCI (12%), Primero, Churchill. Valuation only ~$11M mkt cap vs. peers many times higher with fewer partnerships. Catalysts: assays (Donner/Falcon West), Teck-funded exploration, potential Canadian government CMIF funding, and further strategic/offtake deals.

BSD Analysis:
Grid is unusual among juniors: diversified commodity exposure, Tier-1 partner, existing offtake, and mill access—removing two of the biggest risks (processing + sales). Cesium is the ace card: only a handful of deposits globally, nearly all under Chinese control. High-grade Falcon West intercepts (>10% Cs₂O) are strategically important and could make Grid one of the few Western-aligned sources. The market ignores this due to its microcap status, but institutional holders and Teck’s involvement suggest validation. Near-term assays will determine whether cesium becomes a company-maker. Lithium provides scalable exposure to EVs, while Teck partnership unlocks nickel without Grid’s capital. Risks: extreme small-cap illiquidity, funding dependence on grants/JVs, commodity volatility, and geopolitical noise around China supply chains. If Falcon West assays confirm scale, the re-rating could be swift.

Pitch Summary:
Tecogen has moved from early conversations to securing a pilot with Vertiv, demonstrating rare execution for a microcap. While the recent raise was poorly priced, the author argues it was necessary to win the pilot project. He views the widely discussed 60-unit chiller order as too speculative to underwrite until the pilot succeeds. The key upside driver is the potential for the pilot to materially alter Tecogen’s financial profile and validate its technology at scale. The Vertiv relationship also raises realistic acquisition optionality. Despite concerns about the raise, the author believes execution has been strong overall. He considers recent highs overstretched but finds the current valuation reasonable, with upside tied to execution.

BSD Analysis:
Tecogen benefits from secular demand for high-density data-center cooling and industrial energy efficiency. Its chiller and cogeneration solutions align with the industry shift toward liquid-cooling architectures. A successful Vertiv pilot could unlock access to global distribution and significantly improve commercial scalability. The primary risks are capital constraints, volatility typical of microcaps, and uncertain conversion from pilot to large orders. The poorly executed raise highlights financing fragility. However, validation by an industry leader like Vertiv could meaningfully de-risk adoption and create acquisition optionality. If the technology proves superior in real-world environments, Tecogen’s earnings power could reset substantially higher relative to historical levels.

Actual Post Content:
$TGEN not too much to share beyond what's already been said. Within 1 year we've gone from talking about data centers to partnering with Vertiv and securing a pilot. It's easy to forget how different that is from most microcap's execution. However, there was also a frankly botched raise; $5 was absurdly low in my view. Negatives from this Q: I personally am discounting the 60 chiller order potential without the pilot just mentally. I don't want to underwrite that. I personally wouldn't bring it up until it was far closer to completion as it just sounds too good to be true and will invite short term holders. And the raise was a bit silly as discussed. They clearly raised at far too low a price and didn't handle it well. Positives from this Q: The raise was for a good reason in terms of winning this pilot at least. I am pretty comfortable underwriting the successful pilot -> grow with customer path and I think that will be enough to be highly material for financial performance. The one thing to add incrementally that I haven't seen discussed is that validating the technology in this setting makes them viable for $VRT as an eventual acquisition target (which frankly, I feel like would naturally make sense... why are they bothering with these guys if they aren't potentially a selling point for Vertiv). Conclusion: In terms of actual numbers—not financial advice—I feel like $11.5 was pretty frothy. I feel like it's around where it should be right now on past accomplishments, and obviously you can adjust that based on how confident you are in future execution. Besides the raise I've been pleased with execution.

URL: https://x.com/Mike10947310/status/1955666952312991951

Pitch Summary:
Domino's Pizza Group (DOM.L) is presented as a deeply discounted U.K. consumer staple–like equity, trading at roughly 10–11× earnings despite consistent capital returns. The company has repurchased ~3.2% of shares annually over the past five years, offers a ~5.4% dividend yield, and maintains a manageable balance sheet with net debt at ~39% of market cap. The pitch argues the valuation implies a structurally broken business with permanently negative organic growth and zero returns on incremental capital—an assumption viewed as implausible for a mass-market, value-oriented food brand in the U.K. While not as optically cheap as certain prior U.K. dislocations, DOM is framed as a global outlier versus comparable consumer staples. The author views further downside as an opportunity to scale a tactical position.

BSD Analysis:
Quick-service restaurant franchises with delivery scale occupy a defensible niche, combining habitual demand, localized pricing power, and capital-light unit economics. Domino’s Pizza Group retains a strong competitive position in the U.K. through brand ubiquity, logistics density, and franchise leverage, which together support durable cash generation even in low-growth environments. Secular pressures—food inflation, labor costs, and delivery competition—have compressed sentiment, but these are cyclical headwinds rather than structural impairments. The company’s demonstrated commitment to buybacks and dividends suggests underlying free cash flow remains robust. The core risk is prolonged real-income pressure on consumers, which could cap volume growth and reduce ROIIC on new stores. However, the current multiple already discounts a no-growth, value-trap scenario. If earnings merely stabilize and capital returns persist, the equity offers an attractive yield-driven return profile. Any normalization in consumer demand or cost pressures would likely drive multiple expansion from depressed levels.

Actual Post Content:
It's becoming increasingly likely that $DOM.L becomes my next tactical strike in the U.K. Perhaps a 1.5% position but I'd be prepared to go up to 5% if the price keeps dropping. I keep staring down these financials every day and they make no sense. It's fuckin' pizza, lads. And they'll literally eat anything in the U.K. This thing is trading at 10x-11x earnings with a history of buying back 3.2% of shares per year over the last 5 years, a 5.4% dividend, and a pretty modest balance sheet at 39% net debt to market cap. It just doesn't make sense unless you think this is suddenly permanently a negative organic growth business with 0 ROIIC. It's strange. Not quite as cheap as $ABF.L at its lows or $BME.L, but certainly a global outlier in terms of global consumer staple comps (if you consider shitty pizza a staple).

URL: https://x.com/taobanker/status/1955761799053119529

Pitch Summary:
AI Robotics is positioned as a high-growth Japanese AI company centered around its proprietary, AI-driven marketing automation platform “SELL.” Management is guiding to an aggressive growth trajectory, targeting a doubling of revenue and profits in each of the next four fiscal years. The company trades on a forward P/E of ~20x for FY ending March 2026, which the pitch frames as attractive given the growth outlook. Historically focused on consumer goods manufacturers and marketing agencies, AI Robotics has been expanding the application of its technology since 2021. Strong Q1 results triggered a sharp positive market reaction, with shares rising over 16%, further supported by a stock split that increased visibility and liquidity.

BSD Analysis:
The marketing technology industry is structurally attractive but highly competitive, with value accruing to platforms that demonstrably automate spend optimization and reduce customer acquisition costs. AI Robotics’ competitive positioning hinges on the depth and efficacy of its proprietary AI workflows, which, if validated at scale, can support strong operating leverage and customer stickiness. Secular tailwinds from AI adoption and enterprise demand for automated marketing solutions underpin the growth narrative, particularly in Japan where digital transformation remains underpenetrated. However, growth targets imply flawless execution, rapid customer expansion, and sustained pricing power, leaving little room for error. Key risks include customer concentration, competitive pressure from global martech incumbents, and potential margin dilution as the company scales. Valuation appears reasonable relative to stated growth ambitions but would quickly look demanding if growth decelerates. The stock’s recent momentum and split-driven attention may compress future upside near term. Long-term returns will depend on whether SELL proves to be a durable platform rather than a niche solution riding early AI enthusiasm.

Actual Post Content:
$247A.T AI Robotics This Japanese stock I own plans to double revenue and profit in each of the next four fiscal years! Current forward P/E for FY ending March 2026: 20. Today, the company reported its Q1 results — here’s a quick thread on the numbers. ➢ Company overview: At the core of the business is its proprietary AI-driven marketing platform ‘SELL,’ which automates all key marketing processes. In the past, this technology was offered to consumer good manufacturers and marketing agencies. Since 2021, AI Robotics has used BTW the stock price is up over 16% this morning 💪🏻 Now one of my largest positions, as I added to it with a market order at the open. Could definitely be a stock you’d like! My DMs are always open if you have any questions. Stock split. This almost gave me a heart attack a few hours ago, as I also use IBKR for the stock 😅

URL: https://x.com/stock_logging/status/1955584629395870122

Pitch Summary:
Private Bancorp of America (CalPrivate Bank) is a $2.5B asset community bank headquartered in La Jolla, CA. Since Rick Sowers became CEO in 2020, PBAM has transformed its performance profile, generating ROEs consistently above 15% with ROA >1.5%. Its strategy focuses on serving HNWIs, professionals, and small businesses in coastal Southern California—markets underserved by large banks but with high deposit productivity. The bank maintains a conservative loan book (80% CRE-backed, ~53% LTV), almost no credit losses, and strong efficiency ratios in the mid-40s. Management targets doubling assets within 5 years without proportional cost growth. Shares trade at ~1.35x book, modest for a bank ranked in the top decile nationally for performance. Uplisting from OTC is a likely medium-term catalyst, along with selective banker hires and organic franchise growth.

BSD Analysis:
PBAM offers a rare small-cap bank story with both growth and quality. Management’s track record since 2020 shows disciplined underwriting, cost control, and franchise expansion in one of the richest U.S. banking markets. The balance sheet is conservative, efficiency improving, and reinvestment runway is long given limited current penetration. At ~1.35x P/B with sustainable mid-teens ROE, investors can earn low-to-mid teens IRRs through compounding, with upside from multiple expansion if uplisting occurs. Key risks are cyclicality in CRE, California-specific economic shocks, and key-man dependence on Sowers. Overall, this is a clean, high-quality bank compounding story that compares favorably to other California peers with more complexity or governance risk.

Pitch Summary:
PepGen is a clinical-stage biotech developing PGN-EDODM1, an antisense oligonucleotide for myotonic dystrophy type 1 (DM1). DM1 is a debilitating multisystem disease caused by toxic RNA repeats with no disease-modifying therapies available. PepGen’s approach differs from peers (Avidity, Dyne) by directly binding CUG repeats, preventing MBNL protein sequestration. Early Phase 1 single-dose data showed promising splicing correction (12–29%) versus peers’ multi-dose results. Key readouts ahead: 15mg/kg single dose in 4Q25 and early multi-dose data in 1Q26. RA Capital owns ~33%, with board seats and historical activism ensuring shareholder-friendly actions. At ~$38M market cap (half of net cash), valuation is severely depressed versus peers (Avidity $6B, Dyne $1.6B). Upside case: multi-bagger if biomarker efficacy and safety are confirmed; downside: cash-backed reverse merger potential, supported by RA’s track record.

BSD Analysis:
PepGen offers a high-risk/high-reward setup with asymmetric payoff. The DM1 program has credible biological rationale and early biomarker data that compare favorably to competitors, albeit in tiny cohorts. Near-term catalysts (4Q25/1Q26) could re-rate shares multiple-fold if splicing correction scales with dose and functional improvements appear. RA Capital’s large stake and activist reputation provide a credible margin of safety against value-destructive behavior, distinguishing PEPG from typical “zombie” biotechs. That said, trial failure risk is high, competition is ahead in development, and cash burn remains significant. For sophisticated investors, this resembles a venture-style bet where success could yield >5x, while failure may still preserve value via RA-led strategic alternatives. Position sizing is critical; this is best treated as a speculative satellite holding.